Oba testa otkrivaju crijevnu upalu potaknutu neutrofilima, ali kalprotektin je obično korisniji alat za kvantitativno praćenje. Pravi rezultat je onaj koji mijenja sljedeću kliničku odluku - a ne onaj koji vam dodjeljuje dijagnozu IBD-a.
- Kalprotektin ispod 50 µg/g je općenito umirujući kod odraslih osoba sa sumnjom na IBS kada nema alarmantnih znakova.
- Laktoferin je protein neutrofila; mnogi kvantitativni testovi koriste manje od 7,25 µg/g kao negativno, ali laboratorijske granične vrijednosti variraju.
- Visoki markeri stolice ukazuju na crijevnu upalu, a ne na specifičnu dijagnozu; infekcija, NSAIL-i, divertikulitis i kolorektalna neoplazija mogu povisiti oba.
- Granični kalprotektin od 50–150 µg/g često zahtijeva ponovno uzimanje uzorka nakon 2–6 tjedana umjesto neposredne kolonoskopije.
- Kalprotektin iznad 250 µg/g povećava zabrinutost za aktivnu upalu sluznice i obično potiče klinički pregled, testiranje na crijevne infekcije ili planiranje endoskopije.
- Normalni rezultati čini manje vjerojatnim aktivnu crijevnu IBD, ali ne može pouzdano isključiti izoliranu bolest tankog crijeva.
- praćenje IBD-a koristi simptome plus biomarkere, CRP, markere anemije, slikovne pretrage i endoskopiju; niti jedan marker stolice samostalno ne dijagnosticira pogoršanje.
- Hitni simptomi poput crne stolice, stalne vidljive krvi, vrućice, jake boli, nesvjestice ili dehidracije zahtijevaju liječnički pregled bez obzira na rezultat markera.
Koji marker stolice prvo odabrati?
Fekalni kalprotektin je obično marker upale stolice prvog izbora jer je široko dostupan, kvantitativan i ima najjaču ulogu u odvajanju vjerojatne upalne bolesti crijeva od funkcionalnih crijevnih simptoma. Test fekalne laktoferine rezultati su razumna alternativa kada je to lokalno validirani test, ali naručivanje oboje na početku rijetko mijenja skrb.
Za osobu s 6 tjedana rijetke stolice, grčeva i bez gubitka težine ili rektalnog krvarenja, obično bih započeo s kalprotektinom plus ciljanim testiranjem na infekcije, a ne kolonoskopijom. Rezultat ispod 50 µg/g čini značajnu upalu debelog crijeva manje vjerojatnom, dok jasno povišen rezultat daje razlog za daljnje pretrage. Smjernice AGA za kronični vodeni proljev podržavaju kalprotektin ili laktferin kao probirne testove za upalna stanja (Smalley et al., 2019).
Odaberite laktferin kada ga vaša gastroenterološka služba dosljedno koristi, kada laboratorij izvješćuje o validiranoj kvantitativnoj vrijednosti ili kada je uključen u obradu zaraznog proljeva. Nemojte ga odabrati jer zvuči specifičnije: oba proteina se oslobađaju kada neutrofili uđu u lumenu crijeva. Praktično pitanje je može li vaš liječnik usporediti rezultat s vašim prethodnim uzorcima koristeći isti test.
Kantesti je Analizator krvnih testova s umjetnom inteligencijom koji stavlja povezane rezultate poput hemoglobina, CRP, albumina i indeksa željeza uz izvještaj o markeru stolice; ne zamjenjuje test stolice ili dijagnozu liječnika. Ako se umor pridruži proljevu, pretraga krvi za proljev može pomoći u identifikaciji dehidracije, anemije ili gubitka elektrolita koji mijenjaju hitnost.
Korisno je pravilo
Prvo upotrijebite jedan validirani marker, ponovite isti marker kada je rezultat graničan ili pri praćenju liječenja, a dvostruko testiranje rezervirajte za specifično gastroenterološko pitanje. Promjena testa usred praćenja stvara prividne trendove koji mogu biti laboratorijska buka, a ne biologija.
Što zapravo otkriva fekalni kalprotektin
Kalprotektin mjeri protein koji veže kalcij i cink, a uglavnom se oslobađa iz neutrofila u crijevnom traktu. Viša koncentracija u stolici odražava migraciju neutrofila u crijevo, što je uobičajeno kod aktivne IBD, ali se javlja i kod nekoliko stanja koja nisu IBD.
Kalprotektin je kompleks S100A8/S100A9 proteina i ostaje relativno stabilan u stolici nekoliko dana na sobnoj temperaturi—jedan od razloga zašto dobro funkcionira kao test za kućno prikupljanje. Njegova biološka snaga je lokalnost: za razliku od CRP-a, odražava staničnu aktivnost u crijevnom lumenu, a ne sistemski odgovor akutne faze cijelog tijela. Stoga normalan CRP ne poništava visok rezultat kalprotektina.
U odrasloj praksi, laboratoriji obično klasificiraju manje od 50 µg/g kao normalno i više od 150–250 µg/g kao sve više kompatibilno s aktivnom upalom crijeva. Ovo su pragovi odlučivanja, a ne univerzalne biološke granice. Neke europske službe koriste 100 µg/g kao prag za upućivanje, dok pedijatrijski i referentni intervali specifični za test mogu značajno varirati.
Vidio sam 28-godišnjaka s kalprotektinom od 680 µg/g, normalnim CRP-om i na kraju ulceroznim kolitisom ograničenim na rektum i sigmoidno crijevo. Taj obrazac nije neuobičajen: lokalna upala sluznice može biti aktivna bez snažnog sistemskog signala. Naš fecal calprotectin range guide explains why the laboratory’s own method and units should stay attached to every result.
Što fekalni laktoferin otkriva drugačije
Lactoferrin detects another neutrophil-derived protein and answers nearly the same biological question as calprotectin: is there active intestinal neutrophil inflammation? It does not identify ulcerative colitis, Crohn’s disease, bacterial colitis, or another cause on its own.
Lactoferrin is an iron-binding glycoprotein stored in neutrophil secondary granules and released during activation. A positive qualitative fecal lactoferrin test is useful because it argues against uncomplicated IBS in the right clinical setting. Quantitative assays vary: one commonly used method defines a negative value as less than 7.25 µg/g, so never apply a calprotectin cutoff to a lactoferrin report.
The evidence does not show that lactoferrin is categorically superior. In a diagnostic meta-analysis, Wang and colleagues found fecal lactoferrin had pooled sensitivity of 82% and specificity of 95% for distinguishing IBD from non-IBD controls, although accuracy estimates shift with disease prevalence and study design (Wang et al., 2015). That impressive specificity still does not convert a positive result into an IBD diagnosis.
A positive lactoferrin result is especially worth discussing when diarrhoea began abruptly after travel, antibiotics, contaminated food exposure, or contact with someone unwell. In those situations, clinicians usually add pathogen testing rather than jumping straight to an IBD label. Our guide to rezultatima kulture stolice covers what a negative or mixed-growth report can and cannot settle.
Kako čitati granične vrijednosti bez pretjerane reakcije
A calprotectin value below 50 µg/g is usually normal for adults, 50–150 µg/g is often an indeterminate zone, and values above 250 µg/g raise concern for active inflammation. Lactoferrin uses assay-specific cutoffs, commonly a qualitative positive or a quantitative threshold near 7.25 µg/g.
The 50 µg/g calprotectin threshold is designed for sensitivity: it catches most clinically significant inflammatory disease at the cost of some false positives. The 250 µg/g threshold is more useful for specificity and for monitoring established IBD. Between them lies the frustrating middle, where medication exposure, recent gastroenteritis, age, and trajectory matter more than a single number.
A change from 72 to 94 µg/g is often less meaningful than a change from 85 to 430 µg/g, particularly if both samples were tested by the same laboratory. Stool consistency can influence extraction and biological variation is real. Dr. Thomas Klein’s practical advice is to record NSAID use, recent infection, menstrual contamination, and collection date before interpreting a modest rise.
For a disciplined approach to serial values, compare the sample date with symptoms and related labs rather than treating every flagged result as disease progression. Our vodič za trend krvne slike explains the same principle of reference change and analytic variation in laboratory medicine.
Zašto oba markera mogu biti povišena bez IBD-a
Elevated stool inflammation markers occur with enteric infection, NSAID exposure, diverticulitis, colorectal neoplasia, microscopic colitis and IBD. The result confirms an inflammatory signal; it does not disclose the cause, location, duration, or severity by itself.
Non-steroidal anti-inflammatory drugs can raise fecal calprotectin, sometimes substantially, by increasing intestinal permeability and causing small mucosal injuries. Ibuprofen, naproxen and diclofenac matter; a clinician may suggest withholding them if medically safe before repeating the test. Do not stop prescribed aspirin, anticoagulants, or pain medicines without asking the prescriber first.
Acute bacterial gastroenteritis may produce calprotectin values above 500 µg/g and a positive lactoferrin, which is why a stool pathogen panel can be more informative than an urgent colonoscopy in the first days of illness. Conversely, giardiasis may cause prolonged diarrhoea with less striking neutrophilic marker elevation. The symptom timeline often carries more diagnostic weight than patients expect.
Kantesti je usluzi za tumačenje laboratorijskih testova AI that can flag an inflammation pattern such as low hemoglobin, low albumin, thrombocytosis and raised CRP for clinician review, but those blood findings do not prove the source is intestinal. For people with blood in the stool, FIT follow-up and colonoscopy timing is a separate issue from calprotectin and should not be delayed.
Kada normalan rezultat još uvijek može promašiti bolest
Normal calprotectin or lactoferrin makes active colonic inflammation less likely, but it cannot fully exclude Crohn’s disease, particularly mild or isolated small-bowel disease. A normal result also does not explain persistent weight loss, iron-deficiency anemia, nocturnal diarrhoea, or recurrent visible bleeding.
Small-bowel Crohn’s disease can shed less neutrophil protein into a stool sample than extensive colitis, especially when lesions are proximal or mild. This is one reason symptoms and alarm features overrule a reassuring number. The ECCO-ESGAR diagnostic guideline recommends integrating biomarkers with ileocolonoscopy and cross-sectional imaging when IBD remains clinically suspected (Maaser et al., 2019).
A 46-year-old with calprotectin of 38 µg/g, ferritin of 7 ng/mL, and progressive fatigue deserves evaluation for gastrointestinal blood loss or malabsorption even if bowel frequency is normal. In my experience, the combination of iron deficiency and unexplained symptoms is much more consequential than a single low stool marker. Read our low ferritin and gut clues for the usual next laboratory questions.
Celiac disease, bile acid diarrhoea, pancreatic insufficiency and many medication effects may cause symptoms with normal stool inflammation markers. A normal test is therefore a fork in the road toward non-inflammatory diagnoses, not a declaration that symptoms are psychological or unimportant.
Što učiniti s graničnim rezultatom kalprotektina
A borderline fecal calprotectin result of 50–150 µg/g is commonly repeated after 2–6 weeks if symptoms are stable and there are no alarm features. The repeat should use the same laboratory method and should be timed away from a recent gastrointestinal infection where possible.
Before retesting, clinicians review NSAIDs, proton-pump inhibitors, antibiotics, acute infections, strenuous endurance exercise and age-related risk. There is no universally agreed washout interval for every medicine. A pragmatic plan is often 2 weeks after an acute illness has settled, provided symptoms do not signal a need for earlier care.
If the repeat falls from 118 to 32 µg/g and symptoms settle, invasive testing may be avoidable. If it rises from 96 to 310 µg/g, the direction adds useful evidence even before an endoscopy result arrives. This is why a single borderline value should rarely trigger panic—or false reassurance.
Naše borderline calprotectin follow-up guide lays out the questions to bring to a primary-care or gastroenterology appointment. A short symptom diary with stool frequency, nighttime waking, fever and medication dates is usually more useful than obsessively checking food triggers.
Kako kliničari koriste markere nakon dijagnoze IBD-a
In established IBD, calprotectin is most useful for tracking objective intestinal inflammation and helping decide whether symptoms represent a flare, infection, IBS overlap, or treatment failure. Lactoferrin can also follow activity, but calprotectin has more guideline-supported thresholds for treat-to-target monitoring.
Symptoms and mucosal activity frequently diverge. A patient with ulcerative colitis may feel well while calprotectin climbs from 80 to 360 µg/g, or have urgent bowel motions from bile acid malabsorption while calprotectin remains 28 µg/g. The 2023 AGA ulcerative colitis biomarker guideline advises combining symptoms with biomarkers rather than relying on either alone (Singh et al., 2023).
For remission monitoring, many clinicians view less than 150 µg/g as reassuring, while more than 150 µg/g may warrant repeat testing, endoscopy, or treatment review depending on symptoms and prior disease behaviour. In active symptomatic ulcerative colitis, more than 250 µg/g supports ongoing inflammation. Cutoffs are guides, not instructions to alter biologic treatment without specialist input.
Kantesti AI je platforma za tumačenje biomarkera pomoću AI-a that organizes blood-test trends around a patient’s reported treatment dates; it cannot assess stool endoscopic severity from a number alone. Patients taking biologics should also understand which blood safety tests monitor treatment and which symptoms require prompt contact with their IBD team.
Kako pogreške pri uzimanju uzoraka i vrijeme utječu na rezultate
Collection quality affects stool marker interpretation because a contaminated, delayed, or poorly sampled specimen can be rejected or produce a less reliable measurement. Most laboratories want a small stool portion placed into the supplied sterile container without toilet water or urine.
Loose stool is usually acceptable for calprotectin and lactoferrin testing; do not wait for a formed sample if diarrhoea is the clinical problem. Avoid collecting from toilet water, and tell the laboratory if the sample includes visible menstrual blood. Storage instructions vary by kit, but many allow short room-temperature transport because calprotectin is comparatively stable.
Sampling a day after a marathon, a bout of gastroenteritis, or colonoscopy bowel preparation may answer the wrong question. Endurance exercise can transiently increase gut permeability and provoke gastrointestinal symptoms. If you are an endurance athlete without red flags, consider timing collection away from a major event; our vodiču za laboratorijske nalaze za sportaše izdržljivosti explains why context changes test interpretation.
The thing is, a perfect collection does not make a nonspecific biomarker specific. A high-quality sample improves confidence in the measurement; it cannot replace the clinical history, examination, and differential diagnosis.
Koji krvni testovi čine marker stolice korisnijim
A CBC, CRP, ferritin, albumin, kidney function and celiac serology often add more clinical value to a raised stool marker than ordering a second stool inflammation protein. The concerning pattern is not any one abnormality but several results that point toward inflammation, malabsorption, or blood loss.
Low hemoglobin, ferritin below 15 ng/mL, albumin below the laboratory reference range, raised platelets, or raised CRP can strengthen concern for clinically meaningful bowel disease. None is diagnostic of IBD. In fact, CRP may remain normal in mild ulcerative colitis, and ferritin can look falsely normal when inflammation raises it as an acute-phase protein.
Kantesti je Alat za analizu krvnih nalaza uz pomoć AI-a that reads a CBC, iron studies and CRP in the same clinical frame, including whether a changing hemoglobin level might justify earlier review. Dr. Thomas Klein routinely cautions that an isolated CRP of 12 mg/L is nonspecific, whereas CRP 12 mg/L plus falling albumin and a calprotectin of 740 µg/g is a much more actionable cluster.
For patients whose iron values seem contradictory, our iron studies research guide explains transferrin saturation and ferritin during inflammation. A CBC result guide can also help you identify whether anemia is microcytic, inflammatory, or mixed.
Kada naručivanje oba testa može biti opravdano
Ordering calprotectin and lactoferrin together is usually unnecessary, but it can be reasonable when a specialist is reconciling discordant symptoms, a prior assay cannot be repeated, or a local pathway requires confirmation. Concordant results modestly increase confidence in an inflammatory signal; discordant results usually trigger review, not arithmetic averaging.
A high calprotectin with negative lactoferrin may reflect assay timing, a result near the cutoff, specimen heterogeneity, or analytical differences. A low calprotectin with positive lactoferrin deserves the same disciplined response: verify collection, review the exact assay, check symptoms and test for infection when appropriate. Neither combination has a validated shortcut to diagnosis.
Dual testing can also be useful in research settings where a protocol prespecifies both biomarkers. That is different from routine patient care, where duplicate testing can add cost without improving decisions. Ask the ordering clinician a simple question: “What will we do differently if the second test is positive?”
If a report looks internally inconsistent, use our vodič za kvalitativno naspram kvantitativnog testa to understand why “positive” and “high” are not interchangeable laboratory statements. Consistency of method matters more than collecting every available marker.
Što zapravo potvrđuje ili isključuje IBD
IBD is diagnosed through a synthesis of symptoms, ileocolonoscopy with tissue sampling, histology, laboratory tests, and sometimes MRI or CT enterography—not from calprotectin or lactoferrin alone. Stool markers help decide who needs these investigations and whether inflammation may be changing over time.
Colonoscopy allows direct assessment of the terminal ileum and colon and permits tissue examination for chronic inflammatory features, infection, microscopic colitis, dysplasia, and other causes. Imaging is particularly valuable when Crohn’s disease may involve small bowel beyond the reach of a standard colonoscopy. A stool marker is a triage signal, not a microscopic diagnosis.
Do not confuse a fecal immunochemical test with either inflammatory marker. FIT detects human hemoglobin and is used primarily in colorectal cancer screening or lower-GI bleeding pathways, whereas calprotectin and lactoferrin detect neutrophil products. Our comparison of FIT and FOBT explains why a negative inflammation marker does not substitute for recommended cancer screening.
As of September 4, 2026, no major gastroenterology guideline recommends diagnosing Crohn’s disease or ulcerative colitis from a single stool biomarker threshold. That restraint protects patients from both missed disease and unnecessary lifelong diagnostic labels.
Simptomi koji nadmašuju bilo koji rezultat testa stolice
Persistent visible rectal bleeding, black tarry stool, severe abdominal pain, fever, fainting, dehydration, rapidly worsening weakness, or unintended weight loss need timely medical assessment regardless of calprotectin or lactoferrin. A normal result should never be used to wait out a potentially urgent symptom pattern.
The urgent concern is physiology, not the label on a laboratory report. Frequent watery diarrhoea can produce low potassium, acute kidney injury, and orthostatic symptoms before an inflammation marker returns. Adults with inability to keep fluids down, confusion, fainting, or minimal urine output should seek urgent care.
New bowel symptoms after age 50, a strong family history of colorectal cancer, and iron-deficiency anemia alter the threshold for colon evaluation even when calprotectin is low. A stool marker does not assess cancer risk comprehensively. Our mucus in stool red-flag guide distinguishes common benign patterns from symptoms that need examination.
Children, pregnant people, older adults, and people using immune-suppressing medicines need individualized triage because their baseline risks differ. If you are unsure whether symptoms are urgent, contacting a local clinician or urgent-care service is safer than trying to interpret a number in isolation.
Praktičan razgovor nakon vašeg rezultata
The most useful follow-up question is: “Does this result change my need for infection testing, repeat testing, imaging, or endoscopy?” Bringing the exact value, assay name, symptom timeline, medicines, and previous results makes that conversation faster and more clinically precise.
Bring a list of the previous 14 days: stool frequency, overnight symptoms, fever, weight change, travel, antibiotics, NSAIDs, and family history. A calprotectin of 180 µg/g after a 3-day febrile diarrhoeal illness calls for a different plan than the same result after 4 months of nocturnal diarrhoea and weight loss.
Kantesti AI can help you organize accompanying blood reports before an appointment, but diagnosis and treatment decisions belong with the clinician who can examine you and arrange definitive testing. Our pristup medicinskoj validaciji explains how clinical oversight and source checking are built into responsible laboratory interpretation.
For complex cases, ask who will own the follow-up and when you should expect a repeat result or referral decision. The clinicians on our Medicinski savjetodavni odbor emphasize that a documented plan beats a vague instruction to “recheck later,” especially when inflammation markers and anemia move in the same direction.
Ključni zaključak usmjeren na odluku
Choose calprotectin first in most settings, use lactoferrin when it is your service’s validated alternative, and do not assume either result diagnoses IBD. A low result shifts attention toward functional and non-inflammatory causes, while a persistently high result identifies people who may need infection testing, specialist review, or endoscopy.
For uncomplicated chronic diarrhoea, one normal marker—calprotectin below 50 µg/g or a negative lactoferrin according to that laboratory—can reduce the likelihood of active inflammatory disease. For a value above 250 µg/g or a positive lactoferrin with persistent symptoms, the next question is cause, not certainty. Infection, medicine exposure, IBD, and other inflammatory conditions remain on the list.
Most patients find the ambiguity hardest in the 50–150 µg/g calprotectin zone. In my experience, the best next step is usually a carefully timed repeat, not a dietary cleanse, self-directed steroid use, or an internet diagnosis. Keep the same laboratory where feasible so the trend is interpretable.
Kantesti-ove vodič uz pomoć AI tehnologije describes how our systems preserve laboratory context while highlighting questions for medical review. The safe use of any AI interpretation is the same here: use it to prepare for a better clinical conversation, never to override red flags or replace diagnostic care.
Često postavljana pitanja
Je li kalprotektin bolji od laktoferina u otkrivanju IBD?
Kalprotektin se obično preferira kod sumnje na IBD jer je široko dostupan kao kvantitativni test i ima uobičajene pragove za praćenje, poput manje od 50 µg/g i više od 250 µg/g. Laktoferin je također koristan biljeg izveden iz neutrofila u stolici i može dobro funkcionirati kada laboratorij koristi validiranu analizu. Nijedan biljeg ne potvrđuje IBD, jer infekcije, NSAIL-i, divertikulitis i druga crijevna stanja mogu povisiti oba. Bolji test je obično onaj koji vaš kliničar može protumačiti uz simptome i ponoviti koristeći istu laboratorijsku metodu.
Koja je razina kalprotektina zabrinjavajuća?
Razina fekalnog kalprotektina ispod 50 µg/g općenito je umirujuća za odrasle osobe bez alarmantnih simptoma, dok se 50–150 µg/g često smatra graničnom i može se ponoviti nakon 2–6 tjedana. Vrijednosti iznad 150–250 µg/g više su zabrinjavajuće za crijevnu upalu, a razine iznad 250 µg/g često potiču klinički pregled ili daljnje pretrage. Točno djelovanje ovisi o testu, simptomima, dobi, primjeni NSAIL-a i je li vrijednost u porastu. Vrijednost od 600 µg/g nakon akutnog bakterijskog proljeva može imati drugačije značenje od 600 µg/g tijekom nekoliko mjeseci kroničnih simptoma.
Može li IBS uzrokovati povišeni kalprotektin ili laktiferin?
Neuremećeni IBS obično ne uzrokuje povišeni fekalni kalprotektin ili laktiferin jer IBS ne proizvodi crijevnu upalu vođenu neutrofilima. Blaga povišenja kalprotektina između 50 i 150 µg/g mogu se pojaviti uslijed nedavne infekcije, upotrebe NSAIL-a, faktora povezanih sa starenjem ili varijacija testa, stoga automatski ne isključuju IBS. Pozitivan laktiferin ili kalprotektin iznad 250 µg/g trebao bi potaknuti procjenu upalnog ili infektivnog uzroka umjesto pretpostavke IBS-a. IBS i IBD mogu postojati istovremeno, što je još jedan razlog zašto simptomi i trendovi imaju važnost.
Can a normal calprotectin rule out Crohn's disease?
Normalan nalaz kalprotektina smanjuje vjerojatnost aktivne upalne bolesti crijeva (IBD) debelog crijeva, ali ne može u potpunosti isključiti Crohnovu bolest, osobito blagu ili izoliranu IBD tankog crijeva. Vrijednost ispod 50 µg/g ne bi smjela nadjačati alarmantne znakove poput anemije zbog nedostatka željeza, gubitka tjelesne težine, noćnog proljeva, perzistentnog krvarenja ili jake obiteljske povijesti bolesti. Kliničari mogu koristiti ileokolonoskopiju, MR enterografiju ili kapsulnu endoskopiju kada je klinička sumnja i dalje visoka. Rezultat je najbolje tretirati kao jedan dokaz koji prilagođava vjerojatnost, a ne kao konačni test isključenja.
Trebam li ponoviti granični rezultat kalprotektina?
Granični rezultat kalprotektina od 50–150 µg/g često se ponavlja nakon 2–6 tjedana kada su simptomi stabilni i nema alarmantnih znakova. Prije ponavljanja, kliničari obično provjeravaju nedavnu gastroenteritis, upotrebu NSAID-a, antibiotike i uvjete prikupljanja, jer svaki od njih može utjecati na vrijednost. Koristite isti laboratorijski test ako je moguće, jer rezultati iz različitih metoda možda nisu izravno usporedivi. Rastući rezultat prema 250 µg/g ili iznad njega općenito ima veću kliničku težinu od stabilnog blagog povišenja.
Mogu li antibiotici utjecati na fekalni kalprotektin i laktiferin?
Antibiotici mogu neizravno utjecati na markere upale stolice liječenjem, poticanjem ili podudaranjem s infektivnim proljevom te promjenom crijevnog mikrobioma. Osobu s proljevom povezanim s antibioticima treba procijeniti zbog uzroka poput Clostridioides difficile, umjesto tumačiti povišeni kalprotektin ili pozitivnu laktoferin kao IBD. Ne postoji pouzdani univerzalni broj dana čekanja nakon antibiotika prije testiranja; vrijeme ovisi o simptomima i kliničkom pitanju. Uporni proljev, vrućica ili bol u trbuhu nakon antibiotika zahtijevaju testiranje pod vodstvom liječnika, a ne samoliječenje.
Isprobajte analizu krvne slike uz AI već danas
Pridružite se više od 2 milijuna korisnika diljem svijeta koji vjeruju Kantesti-u za trenutačnu i točnu analizu laboratorijskih nalaza. Prenesite svoje rezultate krvne slike i dobijte sveobuhvatno tumačenje 15,000+ biomarkera u sekundama.
📚 Referirane znanstvene publikacije
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Urobilinogen u urinskom testu: Potpuni vodič urinalize 2026. Zenodo.. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Kantesti LTD. (2026). Iron Studies Guide: TIBC, Iron Saturation & Binding Capacity. Zenodo.. Kantesti AI Medical Research.
📖 Vanjske medicinske reference
Singh S et al. (2023). AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Gastroenterology.
⚕️ Medicinska izjava o odricanju odgovornosti
Ovaj je članak samo u obrazovne svrhe i ne predstavlja medicinski savjet. Za odluke o dijagnozi i liječenju uvijek se posavjetujte s kvalificiranim pružateljem zdravstvenih usluga.
E-E-A-T signal(i) povjerenja
Iskustvo
Liječnički vođena klinička revizija radnih tokova tumačenja laboratorijskih nalaza.
Stručnost
Fokus laboratorijske medicine na to kako se biomarkeri ponašaju u kliničkom kontekstu.
Autoritativnost
Napisao dr. Thomas Klein, uz recenziju dr. Sarah Mitchell i prof. dr. Hans Weber.
Pouzdanost
Tumačenje utemeljeno na dokazima, s jasnim putovima praćenja kako bi se smanjila uzbuna.